FOMAT Medical Research Restructures Clinical Operations to Support Rapid Expansion
To keep up with growing demand and ensure excellence in clinical research, FOMAT Medical Research has restructured its Clinical Operations department. This strategic move is designed to enhance scalability, improve quality, and reinforce FOMAT’s commitment to patient safety.
Scaling Operations for Future Growth
FOMAT’s Clinical Operations department has been restructured to build a scalable model that supports the company’s rapid expansion across California. This move not only strengthens FOMAT’s infrastructure but also ensures that the organization can continue to meet the evolving needs of Sponsors, Contract Research Organizations (CROs), and patients.
“Our focus on professionalization is a critical aspect of our expansion strategy,” stated Nicholas Focil, CEO of FOMAT Medical Research. “By restructuring Clinical Operations, we’re ensuring that our model is built to scale efficiently while maintaining our dedication to quality and patient care.”
Leadership and Expertise Driving Innovation
The restructuring also includes a leadership change, with Dr. Susana Moyano stepping into the role of Clinical Operations Director. Her experience as an MD and former leader of FOMAT’s Quality Management department positions her perfectly to guide this transformation. Dr. Moyano emphasized the importance of merging her medical and quality management expertise to enhance patient safety and operational efficiency.
Commitment to Quality and Patient Safety
This initiative reflects FOMAT Medical Research’s commitment to delivering excellence. By optimizing processes and prioritizing professionalization, FOMAT is solidifying its role as a trusted partner for Sponsors, CROs, and patients, offering a clinical operations model that’s built to adapt to future demands.
For more details on this restructuring and how it supports FOMAT’s mission, read the full press release here
About FOMAT Medical Research
As California’s largest research site network, FOMAT Medical Research is committed to advancing clinical research and improving patient outcomes. With a focus on innovation and diversity, FOMAT collaborates with Sponsors and CROs to accelerate the development of groundbreaking therapies across various therapeutic areas.